Evaluation of Efficacy of Co-artemisinin in the Treatment of Plasmodium falciparum Malaria in Gombe State, Nigeria

Journal Title: Journal of Advances in Medical and Pharmaceutical Sciences - Year 2017, Vol 13, Issue 1

Abstract

Aim: To evaluate the potency and efficacy of co-artemisinin brands used in the treatment of uncomplicated Plasmodium falciparum malaria in Gombe State North-Eastern Nigeria. Materials and Methods: A total of 185 patients with malaria aged between 5-60 years attending Federal Teaching Hospital Gombe were recruited for the study between April to October, 2014. All patients were weighed and administered with one of the four study drugs for three days under the supervision of a medical staff. Blood samples were collected in an EDTA (Ethylene diamine tetra acetic acid) bottles before and during treatment and both thick and thin films were made for parasitaemia estimation. The PCR was used to distinguish recrudescence from new infection in case of treatment failure. Nested PCR was conducted to compare the genetic polymorphism of Plasmodium falciparum genes. PCR products were resolved by electrophoresis on ethidium bromide stained 1.5% Agarose. Results and Conclusion: Arthemether Lumefantrine and Dihydroartemisinin piperaquine recorded 100% cure rate while Artesunate sulfadoxine-pyrimethemin and Artesunate Amodiaquine recorded a cure rates of 91.4% and 90.5% respectively after polymerase chain reaction (PCR) correction. There was no significant difference between the drugs in terms of antiplasmodial activities (p = 0.780). A total of 15 out of 185 patients came down with symptom similar to that of malaria, 7 of 15 (46.7%) shows similarities in genotyping in pre and post treatment infection (reinfection) and 8 of 15 (53.3%) shows no similarities in the genotype from pre and post treatment infection. Statistically there was no significant difference between pre and post PCR genotyping (p = 0.203).

Authors and Affiliations

M. D. Hassan, Y. Mohammed, B. Muhammad, A. A. Kudi, S. C. Muhammad

Keywords

Related Articles

Comparison of Two Standardizations Used in Antibiotic Susceptibility Testing in Helicobacter pylori

Helicobacter pylori is a bacterium that is widespread in the world's population and constitutes a risk factor for the development of gastric cancer. One possible cause of treatment failure is antimicrobial resistance, in...

Self-medication Practice among Secondary School Students in Ekiti State, Southwest Nigeria

Aims: The aim of this study was to investigate the practice of self-medication and the types of drugs students self-medicate as well as factors influencing practice of self-medication among secondary school students in E...

Assessing the Prevalence and Patterns of Elder’s Abuse in Imo State, Nigeria: A Rural – Urban Comparative Study

This study highlighted the 12-months prevalence of elder abuse in rural and urban communities in Imo State and also compared the pattern of elder abuse in both communities. A cross-sectional study of 371 rural and 314 ur...

Comparative Assessment of the Gastrointestinal Tolerability, Anti-inflammatory and Antipyretic Effects of Diclofenac, Ibuprofen and Nimesulide in White Albino Rats

Aim: NSAIDs is among the commonly used drug in the management of disease conditions. The study carried out comparative assessment of gastric tolerability, antipyrectic and anti inflammatory effect of diclofenac, ibuprofe...

Uroflowmetry Parameter Evaluation of Post Urethroplasty Hypospadia Patients in Padang

Introduction: Hypospadias is the result of an abnormal growth of penis in which the failure of the growth of urethral fold that resulted in the urethral meatus at ventral penis is located proximal from its normal positio...

Download PDF file
  • EP ID EP311604
  • DOI 10.9734/JAMPS/2017/32303
  • Views 94
  • Downloads 0

How To Cite

M. D. Hassan, Y. Mohammed, B. Muhammad, A. A. Kudi, S. C. Muhammad (2017). Evaluation of Efficacy of Co-artemisinin in the Treatment of Plasmodium falciparum Malaria in Gombe State, Nigeria. Journal of Advances in Medical and Pharmaceutical Sciences, 13(1), 1-8. https://europub.co.uk/articles/-A-311604